Care for liver cancer patients at UCLA is provided by the Liver Cancer Program, which is administered through the Division of Liver and Pancreas Transplantation. Clinical care services for the Liver Cancer Program are facilitated primarily by the Dumont-UCLA Liver Cancer Center at UCLA. Additional services may also be offered through the Pfleger Liver Institute and Ronald Reagan UCLA Medical Center.
The Dumont-UCLA Liver Cancer Center offers comprehensive care for liver cancer patients, providing a powerful combination of clinical treatment and medical research. Physicians in the multidisciplinary consortium draw on the collective expertise of hepatologists, oncologists, radiologists, radiation therapists, pathologists and surgeons.
The Pfleger Liver Institute at UCLA offers medical and surgical services for all types of hepatobiliary disorders. Diagnostic, consultative and therapeutic services provided included transplantation of the liver for end-stage liver disease and cancer, transplantation of the pancreas for diabetes mellitus, and surgical and medical treatment options for all forms of liver diseases including primary and metastatic liver tumors, chronic liver disease, viral hepatitis, congenital liver diseases, biliary tract abnormalities, and portal hypertension.
Our multidisciplinary team includes specialists in hepatology, radiology (interventional and diagnostic), and pathology. Our surgical team includes surgeons, anesthesiologists, and nurses who specialize in liver operations and perioperative care. This team also staffs the Dumont-UCLA Liver Transplant Center, the largest liver transplant center in the world, as well as the Dumont-UCLA Liver Cancer Center.
The Liver Transplant Program
Liver transplantation was introduced as a clinical procedure over 30 years ago. Since that time, the number of liver transplants performed yearly in the United States has increased to an annual rate of well over 4,000.
The development of effective immunosuppressive drugs and the refinement of surgical procedures have led to remarkable improvements in the long-term success of liver transplantation. This procedure is now widely recognized as an effective, and preferred, therapeutic option for the treatment of end-stage liver disease.
The Liver Transplant Program at UCLA was inaugurated in 1984 and has grown to be the most active program in the world. Since the program's inception, liver transplants have been performed at UCLA for infants, children and adults, focusing on innovative surgical techniques, advances in immunosuppressive drugs and quality patient care.
As the most experienced liver transplantation program in the western United States, UCLA serves patients from California, Oregon, Washington, and throughout the Southwest, and acts as a tertiary referral center for other transplant programs faced with particularly challenging cases.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
If you are interested in finding out more about these studies, visit our Enroll in a Clinical Trial section for general information and a listing of currently open clinical trials.
For more information about liver cancer services at UCLA, please visit the following links: